April 8 (Reuters) - Biovica International AB  BIOVICb.ST :
    * BIOVICA INITIATES A COLLABORATION WITH MAYO CLINIC TO
STUDY
DIVITUM ®  FOR THE ON-TREATMENT MONITORING OF METASTATIC BREAST
CANCER PATIENTS RECEIVING CDK 4/6 INHIBITORS
    * BIOVICA AND MAYO CLINIC HAVE ENTERED INTO AN AGREEMENT TO
STUDY
CLINICAL BENEFIT OF USING DIVITUM(®)

Source text for Eikon:  ID:nWkrGTrsg 
Further company coverage:  BIOVICb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))